TRASTORNOS ELECTROLÍTICOS

Autores/as

  • Víctor Aníbal Idrovo Vásquez Docente, de la Carrera de Medicina, Universidad Católica de Cuenca, Sede Azogues.
  • Beatriz Patricia Quichimbo Miguitama Médico Tratante del servicio de Emergencias del hospital de Especialidades José Carrasco Arteaga, IESS, Cuenca.

DOI:

https://doi.org/10.55204/trc.v9789i8788.85

Palabras clave:

SALUD, MEDICINA, PATOLOGÍAS

Resumen

Los líquidos y los electrolitos son constituyentes indispensables de cuyo equilibrio depende el normal funcionamiento del organismo, sus alteraciones tanto en exceso como en déficit repercuten negativamente en el estado de salud, su reconocimiento temprano, su oportuna corrección y la reevaluación frecuente son puntos clave para el retorno a la salud. En el siguiente capítulo se revisará las principales alteraciones de los líquidos y electrolitos.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

Wachira B. Fluidos, electrolitos y trastornos ácido-básicos. In: Cydulka R, Fitch M, Joing S, editors. Tintinalli Manual de Medicina de Urgencias. 8th ed. México: Interamericana, McGraw-Hill; 2018. p. 37–59.

Killu K, Sarani B. Manejo de los trastornos electrolíticos y metabólicos que amenazan la vida. In: Fundamentos de Cuidados Críticos en soporte Inicial (FCCS). 6th ed. Estados Unidos: Society of Critical Care Medicine; 2018. p. 337–54.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Guía de práctica clínica sobre el diagnóstico y tratamiento de la hiponatremia. Nefrologia [Internet]. 2017;37(4):370–80. Available from: http://dx.doi.org/10.1016/j.nefro.2017.03.021 DOI: https://doi.org/10.1016/j.nefro.2017.03.021

Broch Porcar MJ, Rodríguez Cubillo B, Domínguez-Roldán JM, Álvarez Rocha L, Ballesteros Sanz MÁ, Cervera Montes M, et al. Documento práctico del manejo de la hiponatremia en pacientes críticos. Med Intensiva. 2019;43(5):302–16. DOI: https://doi.org/10.1016/j.medin.2018.12.002

Pfennig C, Slovis C. Electrolyte Disorders. In: Walls R, Hockberger R, Gausche-Hill M, editors. Rosen´s Emergency Medicine: Concepts and Clinical Practice. 9th ed. Philadelphia: Elsevier Inc; 2018. p. 1516–32.

Levine M. Urgencias electrolíticas: calcio. In: Levine M, Gilmore S, editors. Manual Washington de Medicina de urgencias. 1st ed. Philadelphia: Wolters Klumer; 2018. p. 346–9.

Sterns RH. Diagnostic evaluation of adults with hyponatremia. UpToDate [Internet]. 2020;1–9. Available from: https://www.uptodate.com/contents/diagnostic-evaluation-of-adults-with-hyponatremia

Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, et al. Tratamiento de la hiponatremia secundaria al síndrome de secreción inadecuada de la hormona antidiurética: Algoritmo multidisciplinar. Rev Nefrol. 2014;34(4):439–50.

Pose A, Almenar L, Gavira JJ, López-Granados A, Blasco T, Delgado J, et al. Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project. ESC Hear Fail. 2017;4(2):130–7. DOI: https://doi.org/10.1002/ehf2.12124

Barajas-Galindo DE, Vidal-Casariego A, Gómez-Hoyos E, Guerra-González M. Experiencia clínica con el uso ambulatorio de tolvaptan. Costes y efectividad en nueve casos. Gac Med Mex. 2020;156(1):78–81. DOI: https://doi.org/10.24875/GMM.19005250

Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: A clinical update. Endocr Connect. 2018;7(4):R135–46. DOI: https://doi.org/10.1530/EC-18-0109

Adamczak M, Chudek J, Zejda J, Bartmańska M, Grodzicki T, Zdrojewski T, et al. Prevalence of hypokalemia in older persons: results from the PolSenior national survey. Eur Geriatr Med [Internet]. 2021; Available from: https://doi.org/10.1007/s41999-021-00484-6 DOI: https://doi.org/10.1007/s41999-021-00484-6

Seo WW, Jo SH, Kim SE, Kim HJ, Han SH, Lee KY, et al. Admission serum potassium levels and prognosis of vasospastic angina. Sci Rep [Internet]. 2021;11(1):1–9. Available from: https://doi.org/10.1038/s41598-021-84712-w DOI: https://doi.org/10.1038/s41598-021-84712-w

Han MJ, Kim SH, Shin J ho, Hwang JH. Caffeine-induced hypokalemia: a case report. BMC Nephrol. 2021;22(1):4–9. DOI: https://doi.org/10.1186/s12882-021-02465-0

Ota Y, Obata Y, Takazono T, Tashiro M, Wakamura T, Takahashi A, et al. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study. BMC Nephrol. 2021;22(1):1–12. DOI: https://doi.org/10.1186/s12882-021-02450-7

Repetto HA, Brenzoni L, Tatay D. Hipokalemia. Riesgo de generación por tratamientos. Rev Nefrol Diálisis y Traspl [Internet]. 2017;37(1):62–6. Available from: http://www.revistarenal.org.ar/index.php/rndt/article/view/90

Chen D, Chen D, Li X, Song Q, Hu C, Hu C, et al. Assessment of Hypokalemia and Clinical Characteristics in Patients with Coronavirus Disease 2019 in Wenzhou, China. JAMA Netw Open. 2020;3(6):1–12. DOI: https://doi.org/10.1001/jamanetworkopen.2020.11122

Marti G, Schwarz C, Leichtle AB, Fiedler GM, Arampatzis S, Exadaktylos AK, et al. Etiology and symptoms of severe hypokalemia in emergency department patients. Eur J Emerg Med. 2014;21(1):46–51. DOI: https://doi.org/10.1097/MEJ.0b013e3283643801

Wang X, Han D, Li G. Electrocardiographic manifestations in severe hypokalemia. J Int Med Res. 2020;48(1). DOI: https://doi.org/10.1177/0300060518811058

Yang Y, Chen C, Duan P, Thapaliya S, Gao L, Dong Y, et al. The ECG Characteristics of Patients With Isolated Hypomagnesemia. Front Physiol. 2021;11(January):1–9. DOI: https://doi.org/10.3389/fphys.2020.617374

Li J, Ma H, Lei Y, Wan Q. Diagnostic value of parameters from a spot urine sample for renal potassium loss in hypokalemia. Clin Chim Acta [Internet]. 2020;511(October):221–6. Available from: https://doi.org/10.1016/j.cca.2020.10.024 DOI: https://doi.org/10.1016/j.cca.2020.10.024

DiNicolantonio JJ, O’Keefe JH, Wilson W. Subclinical magnesium deficiency: A principal driver of cardiovascular disease and a public health crisis. Open Hear. 2018;5(1). DOI: https://doi.org/10.1136/openhrt-2017-000668

Agus ZS. Mechanisms and causes of hypomagnesemia. Curr Opin Nephrol Hypertens. 2016;25(4):301–7. DOI: https://doi.org/10.1097/MNH.0000000000000238

Liamis G, Hoorn EJ, Florentin M, Milionis H. An overview of diagnosis and management of drug‐induced hypomagnesemia. Pharmacol Res Perspect. 2021;9(4):1–13. DOI: https://doi.org/10.1002/prp2.829

Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clin Belgica Int J Clin Lab Med [Internet]. 2019;74(1):41–7. Available from: https://doi.org/10.1080/17843286.2018.1516173 DOI: https://doi.org/10.1080/17843286.2018.1516173

Uehara A, Kita Y, Sumi H, Shibagaki Y. Proton-pump inhibitor-induced severe hypomagnesemia and hypocalcemia are clinically masked by thiazide diuretic. Intern Med. 2019;58(15):2201–5. DOI: https://doi.org/10.2169/internalmedicine.2608-18

Gommers LMM, Hoenderop JGJ, Bindels RJM, De Baaij JHF. Hypomagnesemia in type 2 diabetes: A vicious circle? Diabetes. 2016;65(1):3–13. DOI: https://doi.org/10.2337/db15-1028

Park CH, Kim EH, Roh YH, Kim HY, Lee SK. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: A systematic review and meta-analysis. PLoS One. 2014;9(11). DOI: https://doi.org/10.1371/journal.pone.0112558

Sanvas U, Praveen D, Ranadheer Chowdary P, Vijey Aanandhi M. Proton pump inhibitor-induced hypomagnesemia - A review. Drug Invent Today. 2018;10(2):219–21.

Duval M, Bach-Ngohou K, Masson D, Guimard C, Conte P Le, Trewick D. Is severe hypocalcemia immediately life threatening? Endocr Connect. 2018;7(10):1067–74. DOI: https://doi.org/10.1530/EC-18-0267

Qin Y, Sun W, Wang Z, Dong W, He L, Zhang T, et al. A Meta-Analysis of Risk Factors for Transient and Permanent Hypocalcemia After Total Thyroidectomy. Front Oncol. 2021;10(February). DOI: https://doi.org/10.3389/fonc.2020.614089

Karunakaran P, Abraham D, Devadas G, Hussain Z, Kanakasabapathi R. The Effect of Hypomagnesemia on Refractory Hypocalcemia after Total Thyroidectomy: A Single-Center Prospective Cohort Study. Indian J Endocrinol Metab. 2020;24(6):518–24. DOI: https://doi.org/10.4103/ijem.IJEM_681_20

Florenzano P, Cipriani C, Roszko KL, Fukumoto S, Collins MT, Minisola S, et al. Approach to patients with hypophosphataemia. Lancet Diabetes Endocrinol [Internet]. 2020;8(2):163–74. Available from: http://dx.doi.org/10.1016/S2213-8587(19)30426-7 DOI: https://doi.org/10.1016/S2213-8587(19)30426-7

Al Harbi SA, Al-Dorzi HM, Al Meshari AM, Tamim H, Abdukahil SAI, Sadat M, et al. Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock. BMC Pharmacol Toxicol. 2021;22(1):1–9. DOI: https://doi.org/10.1186/s40360-021-00487-w

Imel EA, Biggin A, Schindeler A, Munns CF. FGF23, Hypophosphatemia, and Emerging Treatments. JBMR Plus. 2019;3(8):1–9. DOI: https://doi.org/10.1002/jbm4.10190

Kassianides X, Bhandari S, Edu MC. Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: A narrative review. Drugs Context. 2021;10:1–29. DOI: https://doi.org/10.7573/dic.2020-11-3

Sin JCK, King L, Ballard E, Llewellyn S, Laupland KB, Tabah A. Hypophosphatemia and Outcomes in ICU: A Systematic Review and Meta-Analysis. J Intensive Care Med. 2021;36(9):1025–35. DOI: https://doi.org/10.1177/0885066620940274

Glaspy JA, Wolf M, Strauss WE. Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome. Adv Ther [Internet]. 2021;38(7):3531–49. Available from: https://doi.org/10.1007/s12325-021-01770-2 DOI: https://doi.org/10.1007/s12325-021-01770-2

Descargas

Publicado

2022-07-01

Número

Sección

Libros de Puerto Madero Editorial Académica

Cómo citar

Idrovo Vásquez , V. A., & Quichimbo Miguitama, B. P. (2022). TRASTORNOS ELECTROLÍTICOS. Tesla Revista Científica, 9789(8788). https://doi.org/10.55204/trc.v9789i8788.85